Philips and Masimo Strengthen Partnership to Enhance Patient Monitoring Solutions

technology, wearable sensors, AI in healthcare">
News">
September 12, 2025

Philips and Masimo Extend Partnership to Revolutionize Patient Monitoring

The collaboration will integrate advanced data insights across various patient monitoring systems.
Credit: Koninklijke Philips N.V.

Amsterdam, Netherlands – Global technology leader Philips and medical device innovator Masimo have announced a renewed, multi-year strategic partnership. The aim? To accelerate the growth and wider availability of next-generation
patient monitoring solutions.

Expanding Connected Care technologies

This collaborative effort seeks to substantially broaden access to advanced connected care technologies within healthcare facilities worldwide. The partnership leverages Masimo’s expertise in sensor technology, including its renowned
SET pulse oximetry and Radius PPG, and seamlessly integrates these innovations into philips’ thorough multi-parameter patient monitoring platforms.

According to a report by Grand View Research, the global patient monitoring market is projected to reach $39.14 billion by 2030, driven by an aging population and increasing prevalence of chronic diseases. This partnership positions both
companies to capitalize on this growing demand.

Enhanced Clinical Insights and Interoperability

The integration will provide clinicians with dependable data and actionable insights, accessible through central stations, wearable devices, and standard monitors. This combination offers the adaptability to utilize preferred measurement
technologies within unified systems, increasing efficiency and data accuracy.

The collaboration focuses on streamlining workflows, reducing complexity, and enhancing interoperability – all crucial factors for timely clinical decision-making and continuity of care.

executive Perspectives

Julia Strandberg, Executive Vice-President and Connected care business leader at philips, highlighted the company’s dedication to equipping clinicians with the tools thay need to deliver optimal patient care.She stated that
this partnership enables a rapid response to evolving clinical requirements and market trends, integrating proven technologies into user-pleasant, reliable, and scalable solutions.

Masimo CEO Katie Szyman echoed this sentiment, expressing excitement about continuing collaboration with Philips to bring Masimo’s latest innovations in wearables and artificial intelligence to Philips’ platforms. Expanding their long-standing
collaboration is expected to broaden the reach of Masimo’s advanced technologies to a larger patient base.

Strategic Alignment and Future Developments

Both companies intend to co-develop and jointly promote monitoring solutions aligned with evolving market demands and emerging clinical needs, particularly addressing the growing need for patient mobility.Further collaboration will center on
advancing smart, connected care and expanding access to cutting-edge technologies, including artificial intelligence algorithms.

In July 2025, Philips also forged a strategic partnership with Epic to integrate its cardiac monitoring and diagnostics services suite with Epic’s Aura diagnostics suite, further demonstrating its commitment to interconnected healthcare
solutions.

Did You Know? The use of wearable sensors in patient monitoring is expected to grow exponentially in the next five years,driven by advancements in AI and machine learning.

Company	Key Contribution	Technology Focus
Philips	Multi-parameter patient monitoring platforms	Connectivity,Data Integration,Scalability
Masimo	Sensor technology,Pulse Oximetry,Radius PPG	Accuracy,Wearable Technology,Artificial Intelligence

What impact do you foresee from wider adoption of AI-powered patient monitoring systems? how might these technologies change the role of healthcare professionals?

The Future of Patient Monitoring

the convergence of medical device technology and artificial intelligence is poised to revolutionize patient care. Beyond simply collecting data, these advanced systems will offer predictive analytics, allowing for earlier
intervention and improved outcomes. The trend toward remote patient monitoring is also gaining momentum, offering greater convenience and accessibility for both patients and providers.

Frequently Asked Questions

• What is patient monitoring? Patient monitoring involves tracking a patient’s vital signs and other health indicators to detect changes in their condition.
• What is SET pulse oximetry? SET pulse oximetry is a non-invasive technology that measures the oxygen saturation level in a patient’s blood.
• how will this partnership benefit hospitals? this collaboration will provide hospitals with more advanced and integrated patient monitoring solutions,leading to improved efficiency and patient outcomes.
• What role does AI play in this partnership? AI algorithms will be used to analyze patient data and provide actionable insights to clinicians, improving diagnostic accuracy and treatment planning.
• What is Radius PPG? Radius PPG is a non-invasive technology that measures blood flow and other physiological parameters using light.
• what are the benefits of wearable patient monitoring? Wearable sensors allow for continuous monitoring of patients outside of conventional hospital settings, enabling remote care and early detection of potential problems.

Share your thoughts on this groundbreaking partnership in the comments below!

how does the integration of Masimo’s technologies with Philips’ IntelliVue platform contribute to improved clinical decision-making?

Expanding the Reach of Advanced Monitoring Technologies

Philips and Masimo have announced a strengthening of their long-standing partnership,focused on integrating Masimo’s non-invasive monitoring technologies – including pulse oximetry,regional oximetry,and continuous monitoring of parameters like hemoglobin – with Philips’ thorough patient monitoring and management systems. This collaboration aims to deliver enhanced clinical decision support and improved patient outcomes across the continuum of care, from hospitals to home settings. The core of this advancement lies in improved patient care technology and remote patient monitoring.

Key Technologies Integrated in the Partnership

The expanded partnership builds upon existing integrations and focuses on several key areas:

* Masimo SET® Pulse Oximetry: Widely recognized as a gold standard, Masimo SET® provides accurate and reliable SpO2 and pulse rate measurements, even during patient motion and low perfusion. This is crucial for early detection of patient deterioration.

* Masimo Regional Oximetry (rSO2): This technology measures tissue oxygen saturation in specific regions of the body, providing valuable insights into perfusion and oxygen delivery, especially critically important in neurosurgical and cardiac surgery cases.

* Continuous Hemoglobin Monitoring (SpHb®): Masimo’s SpHb® technology offers non-invasive hemoglobin monitoring, aiding in the detection of anemia and guiding blood transfusion decisions.

* Masimo Gemini™ Advanced Monitoring: Integrating multiple parameters, including arterial blood gas (ABG) and respiratory rate, into a single platform.

* Philips IntelliVue Monitoring Platform: This platform serves as the central hub for integrating Masimo’s technologies, providing clinicians with a unified view of patient data. Hospital monitoring systems benefit substantially from this integration.

Benefits for Healthcare Providers and Patients

This strengthened partnership translates into several tangible benefits:

* Improved clinical Accuracy: Masimo’s signal processing and sensor technologies deliver highly accurate measurements, reducing false alarms and improving clinical confidence.

* Enhanced Patient Safety: Early detection of physiological changes allows for timely intervention, potentially preventing adverse events and improving patient safety. Patient safety solutions are paramount.

* Streamlined Workflows: Integration with the Philips IntelliVue platform simplifies data management and reduces the burden on clinicians.

* remote Monitoring capabilities: the combination of technologies facilitates effective remote patient monitoring, extending care beyond the hospital walls. This is particularly relevant for telehealth solutions and chronic disease management.

* Optimized Resource Utilization: Accurate monitoring data can definitely help optimize resource allocation and reduce unnecessary interventions.

Applications Across Care Settings

The integrated solutions are applicable across a wide range of clinical settings:

* Intensive Care Units (ICUs): Critical care patients benefit from continuous, accurate monitoring of vital signs and tissue oxygenation.

* Operating Rooms: Masimo’s rSO2 and SpHb® technologies provide valuable insights during surgical procedures.

* Post-Anesthesia Care Units (PACUs): Monitoring patients recovering from anesthesia ensures a smooth and safe transition.

* General wards: Continuous monitoring can definitely help identify patients at risk of deterioration.

* Home Healthcare: Remote patient monitoring enables proactive care management and reduces hospital readmissions. Wearable health technology plays a key role here.

Real-World Impact: Case Studies & Examples

While specific, publicly available detailed case studies are limited due to patient privacy, numerous hospitals globally have reported positive outcomes following the implementation of integrated Philips and Masimo solutions. For example, several institutions have demonstrated a reduction in the incidence of postoperative anemia using Masimo SpHb® and optimized transfusion protocols. Furthermore, the use of Masimo SET® in neonatal ICUs has been linked to improved detection of critical congenital heart defects. The integration with Philips systems allows for seamless data analysis and reporting, contributing to quality enhancement initiatives.

Future Directions: Innovation in Patient Monitoring

philips and Masimo are committed to ongoing innovation in patient monitoring. Future developments are likely to focus on:

* Artificial Intelligence (AI) and Machine Learning (ML): Integrating AI/ML algorithms to analyze patient data and provide predictive alerts. Predictive analytics in healthcare is a growing field.

* Expanding Parameter Monitoring: Developing new sensors and algorithms to monitor additional physiological parameters.

* enhanced Connectivity: Improving data connectivity and interoperability with other healthcare systems.

* Personalized Monitoring: Tailoring monitoring strategies to individual patient needs. Precision medicine relies on accurate and personalized data.

Addressing Common concerns: Accuracy and Implementation

A frequent question surrounding advanced monitoring technologies is regarding accuracy and ease of implementation.Masimo’s technologies have undergone rigorous clinical validation, demonstrating high accuracy and reliability.Philips provides comprehensive training and support to ensure seamless integration with existing workflows. Proper sensor request and understanding of the technology’s limitations are crucial for optimal performance. Regular quality control checks and adherence to clinical guidelines are also essential. Clinical decision support systems are only as good as the data they receive and the training of the clinicians using them.